143 related articles for article (PubMed ID: 22532698)
1. Engineered regulation of lysozyme by the SH3-CB1 binding interaction.
Pham E; Truong K
Protein Eng Des Sel; 2012 Jun; 25(6):307-11. PubMed ID: 22532698
[TBL] [Abstract][Full Text] [Related]
2. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
Yamabhai M; Kay BK
Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
[TBL] [Abstract][Full Text] [Related]
3. Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos.
Xue Y; Yuwen T; Zhu F; Skrynnikov NR
Biochemistry; 2014 Oct; 53(41):6473-95. PubMed ID: 25207671
[TBL] [Abstract][Full Text] [Related]
4. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
6. Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase.
Renzoni DA; Pugh DJ; Siligardi G; Das P; Morton CJ; Rossi C; Waterfield MD; Campbell ID; Ladbury JE
Biochemistry; 1996 Dec; 35(49):15646-53. PubMed ID: 8961927
[TBL] [Abstract][Full Text] [Related]
7. 4-Fluoroproline derivative peptides: effect on PPII conformation and SH3 affinity.
Ruzza P; Siligardi G; Donella-Deana A; Calderan A; Hussain R; Rubini C; Cesaro L; Osler A; Guiotto A; Pinna LA; Borin G
J Pept Sci; 2006 Jul; 12(7):462-71. PubMed ID: 16506148
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
[TBL] [Abstract][Full Text] [Related]
9. Versatile retargeting of SH3 domain binding by modification of non-conserved loop residues.
Hiipakka M; Saksela K
FEBS Lett; 2007 May; 581(9):1735-41. PubMed ID: 17418138
[TBL] [Abstract][Full Text] [Related]
10. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
Hiipakka M; Poikonen K; Saksela K
J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
[TBL] [Abstract][Full Text] [Related]
11. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain.
Gouri BS; Swarup G
Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of Fyn-selective SH3 domain ligands via a combinatorial library strategy.
Li H; Lawrence DS
Chem Biol; 2005 Aug; 12(8):905-12. PubMed ID: 16125102
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
14. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
Chan DC; Bedford MT; Leder P
EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
[TBL] [Abstract][Full Text] [Related]
15. Linker length dependent binding of a focal adhesion kinase derived peptide to the Src SH3-SH2 domains.
Lindfors HE; Venkata BS; Drijfhout JW; Ubbink M
FEBS Lett; 2011 Feb; 585(4):601-5. PubMed ID: 21266176
[TBL] [Abstract][Full Text] [Related]
16. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk.
Wang B; Mysliwiec T; Feller SM; Knudsen B; Hanafusa H; Kruh GD
Oncogene; 1996 Oct; 13(7):1379-85. PubMed ID: 8875975
[TBL] [Abstract][Full Text] [Related]
17. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
Hou T; Zhang W; Case DA; Wang W
J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
[TBL] [Abstract][Full Text] [Related]
18. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
